Can You Read These Rxs?

Published Online: Monday, January 14, 2013

Rx 1
When this prescription came into LI Script Long-Term Care Pharmacy in Woodbury, New York, pharmacist Gary Valeich, PharmD, was stumped. Although it was around the holidays, he was able to get in touch with the prescriber to clarify.
Can you read what it says?

Rx 2
With so much information crammed in a tight space, it’s no wonder that Khanh Pham, PharmD, and Leanne Radan, certified senior pharmacy tech, of Walgreens in Las Vegas, Nevada, had trouble reading this Rx.
Can you guess what is being prescribed?

Rx 3
Although the drug name is somewhat decipherable, can you make out any numbers in this prescription? Richard Sottosant, RPh, of CVS Pharmacy in New York, New York, needed help to figure out this looping script.
Can you figure out this Rx?

Rx 4
“This doctor’s office is known for poor handwriting and it’s not unusual for us to have to call for clarification,” said Kelli Moyer, PharmD, of CVS Pharmacy in York, Pennsylvania. Because this messy script came in after hours, it was lucky that the patient could come to the rescue with the drug name.
Can you decipher this prescription?

Have eye-straining, baffling prescriptions?
Send them to us at Pharmacy Times.

Along with a clean photocopy of the prescription itself, your submission must include: (1) the name of your institution and its location; (2) your name and title (PharmD, RPh, Pharm Tech); (3) the correct name of the drug(s), strength, and dosing requirements; and (4) your telephone number. Please mail your submissions to: Can You Read These Rxs?, Pharmacy Times, 666 Plainsboro Road, Suite 300, Plainsboro, NJ 08536.

Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues